Medtech firm Creo ha seen its pioneering device for treating lung cancer being used on a patient for the first time.
The Chepstow-based Alternative Investment listed firm said its non-invasvie Mircoblate Flex device was used by Professor Pallav L Shah, to successfully ablate (remove) soft tissue lung legions on the patient at the Royal Brompton Hospital. The first live treatment is part of a multi-site clinical trial which will see up to 32 patients enrolled.
The device, which has huge commercial potential globally, has been designed to ablate nodules and tumors in several tissue types using the highest frequency microwave energy for tumour ablation.
